Exciva GmbH announced that it has raised ?51 million in a round of funding co-led by new investor Gimv NV and LSP Dementia Fund,a fund managed by EQT Life Sciences on January 20, 2026.The transaction included participation from new investor Fountain Healthcare Partners Ltd., LifeArc, CARMA Fund Management GmbH, Modi Ventures Capital Management LLC and returning investors Andera Partners, LBBW Venture Capital GmbH. The company has issued convertible preferred shares in the transaction. Raphaël Wisniewski of Andera Partners,Philip Scheltens of EQT Life Sciences,Andreas Jurgeit of Gimv NV and Aidan King of Fountain Healthcare Partners Ltd. will join board of directors as a part of the transaction.